Cancer cachexia: Physical activity and muscle force in tumour-bearing rats

Oncology Reports

Volumn 25, Issue 1, 2011, Pages 189-193

  Toledo, Miriam ^a   Busquets, Silvia ^a   Sirisi, Sonia ^a   Serpe, Roberto ^b   Orpi, Marcel ^a   Coutinho, Joana ^a   Martinez, Raquel ^a   Lopez Soriano, Francisco J ^a   Argilés, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

Cancer cachexia; Grip force; Physical activity; Skeletal muscle

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CACHEXIA; COMPUTER PROGRAM; CONTROLLED STUDY; GRIP STRENGTH; LOCOMOTION; MALE; MUSCLE FORCE; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION; YOSHIDA SARCOMA;

ANIMALS; CACHEXIA; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MOTOR ACTIVITY; MUSCLE, SKELETAL; RATS; RATS, WISTAR;

EID: 78650752816     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001060     Document Type: Article

References (26)

1. Tessitore L, Bonelli G, Cecchini G, Amenta JS and Baccino FM: Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys 255: 372-384, 1987.
2. Marzabal M, Garcia-Martinez C, Comas J, Lopez-Soriano FJ and Argiles JM: A flow cytometric study of the rat Yoshida AH-130 ascites hepatoma. Cancer Lett 72: 169-173, 1993.
3. Costelli P, Muscaritoli M, Bonetto A, et al: Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest 38: 531-538, 2008.
4. Fuster G, Busquets S, Ametller E, et al: Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists. Cancer Res 67: 6512-6519, 2007.
5. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ and Argiles JM: Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitinmediated proteolysis. Int J Cancer 61: 138-141, 1995.
6. Costelli P, Garcia-Martinez C, Llovera M, et al: Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitindependent proteolytic pathway. J Clin Invest 95: 2367-2372, 1995.
7. Busquets S, Figueras MT, Fuster G, et al: Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 64: 6725-6731, 2004.
8. Argiles JM, Alvarez B and Lopez-Soriano FJ: The metabolic basis of cancer cachexia. Med Res Rev 17: 477-498, 1997.
9. Llovera M, Garcia-Martinez C, Lopez-Soriano J, et al: Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol 142: 183-189, 1998.
10. Rivera S, Azcon-Bieto J, Lopez-Soriano FJ, Miralpeix M and Argiles JM: Amino acid metabolism in tumour-bearing mice. Biochem J 249: 443-449, 1988.
11. Harvey KB, Bothe A Jr and Blackburn GL: Nutritional assessment and patient outcome during oncological therapy. Cancer 43: 2065-2069, 1979.
12. Nixon DW, Heymsfield SB, Cohen AE, et al: Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 68: 683-690, 1980.
13. DeWys W: Management of cancer cachexia. Semin Oncol 12: 452-460, 1985.
14. Argiles JM, Garcia-Martinez C, Llovera M and Lopez-Soriano FJ: The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev 12: 637-652, 1992.
15. Van Royen M, Carbo N, Busquets S, et al: DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia? Biochem Biophys Res Commun 270: 533-537, 2000.
16. Tessitore L, Costelli P, Bonetti G and Baccino FM: Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys 306: 52-58, 1993. (Pubitemid 23291282)
17. Sinis N, Guntinas-Lichius O, Irintchev A, et al: Manual stimulation of forearm muscles does not improve recovery of motor function after injury to a mixed peripheral nerve. Exp Brain Res 185: 469-483, 2008.
18. Zangarelli A, Chanseaume E, Morio B, et al: Synergistic effects of caloric restriction with maintained protein intake on skeletal muscle performance in 21-month-old rats: a mitochondriamediated pathway. FASEB J 20: 2439-2450, 2006.
19. Garcia-Martinez C, Lopez-Soriano FJ and Argiles JM: Alanine metabolism in rats bearing the Yoshida AH-130 ascites hepatoma. Cancer Lett 87: 123-130, 1994.
20. Costelli P, Llovera M, Garcia-Martinez C, Carbo N, Lopez-Soriano FJ and Argiles JM: Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol. Cancer Lett 91: 73-78, 1995.
21. Mehl KA, Davis JM, Berger FG and Carson JA: Myofiber degeneration/ regeneration is induced in the cachectic apcmin/+ mouse. J Appl Physiol 99: 2379-2387, 2005.
22. Coletti D, Moresi V, Adamo S, Molinaro M and Sassoon D: Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43: 120-128, 2005.
23. Lane-Petter W: The physical environment of rats and mice. Academic Press, London, 1963.
24. Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I and Lundholm K: Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 13: 6379-6385, 2007.
25. Kulstad R and Schoeller DA: The energetics of wasting diseases. Curr Opin Clin Nutr Metab Care 10: 488-493, 2007.
26. Van Norren K, Kegler D, Argiles JM, et al: Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer 100: 713-722, 2009.